A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
Clinical trial NCT07553442 · RECRUITING
Trial details
- NCT number
- NCT07553442
- Sponsor
- Alnylam Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-27
- Primary completion
- 2028-04-01
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.